Chevallier P, Thiebaut A, François S, Chantepie S, Rubio M-T, Labussiere-Wallet H, Brissot E, Maillard N, Huynh A, Coiteux V, Jullien M, Garnier A, Le Bourgeois A, Peterlin P, Guillaume T. A phase II study of ponatinib for prevention of relapse after allogeneic transplantation in FLT3 internal tandem duplication mutation-positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial. haematol [Internet]. 2025Oct.1 [cited 2025Dec.5];110(10):2525-9. Available from: https://haematologica.org/article/view/12030